Oncogenomics and Cancer Heredity
Oncogenomics is a field of medical research that focuses on understanding the genetic basis of cancer. It delves deep into the genomic alterations and mutations that drive the development and progression of cancer. By analyzing the genetic makeup of cancer cells, oncogenomics aims to identify specific genes, known as oncogenes, that play a critical role in promoting tumor growth. This knowledge has paved the way for targeted therapies that can specifically target these genetic abnormalities, offering more precise and effective treatments for cancer patients.
Related Conference of Oncogenomics and Cancer Heredity
September 26-27, 2024
19th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Amsterdam, Netherlands
November 21-22, 2024
17th International Conference on Human Genomics and Genomic Medicine
Dubai, UAE
Oncogenomics and Cancer Heredity Conference Speakers
Recommended Sessions
- Human Genetic Engineering
- Oncogenomics and Cancer Heredity
- Stem Cell Research and Therapy
- Biochemical Genetics
- Cancer Genetics
- Clinical Genetics
- Cytogenetics
- Developmental Genetics
- Epigenetics
- Ethical & Social Implications of Gene Editing
- Gene Therapy
- Gene Therapy and Genetic Counseling
- Genetic Counseling
- Genetic Disorders
- Genomic Medicine & Molecular Diagnostics
- Genomics
- Human genetics
- Immunogenetics
- Medical Genetics
- Molecular Genetics
- Nutritional Genomics
- Pharmacogenetics
- Population Genetics
- Stem Cell Research
Related Journals
Are you interested in
- 3D Bio-Printing and Organ Printing - Stemgen 2024 (UK)
- 3D bioprinting using Stem Cells - Stemgen 2024 (UK)
- Advanced Gene Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Advances in Cell Therapy Research - REGENERATIVE MED MEET 2024 (UK)
- Applications of Stem Cells - Stemgen 2024 (UK)
- Applications of Tissue engineering & Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Bio Banking - Stemgen 2024 (UK)
- Bio Banking Stem cell - Stem Cell 2024 (Ireland)
- Bioengineering Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Bioethics and Genomic Research - HUMAN GENOME 2024 (UAE)
- Bioinformatics - HUMAN GENOME 2024 (UAE)
- Bioinformatics, Machine learning and Statistical methods - HUMAN GENETICS MEET 2024 (France)
- Biologic Scaffolds for Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Biomaterials & Bioengineering - REGENERATIVE MED MEET 2024 (UK)
- Bone Marrow Transplantation - Stem Cell 2024 (Ireland)
- Bone Marrow Transplantation - Stemgen 2024 (UK)
- Cancer Genomics - HUMAN GENOME 2024 (UAE)
- Cancer Stem Cell and Oncology - Stemgen 2024 (UK)
- Cancer Therapies - WORLD CELL THERAPY 2024 (UK)
- Cancer, Cardiovascular Diseases and Genetics - HUMAN GENETICS MEET 2024 (France)
- Cell and Gene Therapy - Stemgen 2024 (UK)
- Cell Culture and Bio processing - WORLD CELL THERAPY 2024 (UK)
- Cell Science and Stem Cell Research - WORLD CELL THERAPY 2024 (UK)
- Cell Therapy and Regenerative Medicine Market - REGENERATIVE MED MEET 2024 (UK)
- Cell Therapy in Pulmonology - WORLD CELL THERAPY 2024 (UK)
- Cellular Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Genetics and Novel Therapies of Genetic Diseases - HUMAN GENETICS MEET 2024 (France)
- Clinical Methods - Stem Cell 2024 (Ireland)
- Clinical Trials and Research in Cell and Gene Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Trials on Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Cognitive Computing - HUMAN GENOME 2024 (UAE)
- Computational Biology - HUMAN GENOME 2024 (UAE)
- Dental Stem Cell - Stemgen 2024 (UK)
- Dental Stem Cells - Stem Cell 2024 (Ireland)
- Diabetes Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2024 (UAE)
- Education and Training in Genomic Medicine - HUMAN GENOME 2024 (UAE)
- Effect of Aging on Stem Cells - Stemgen 2024 (UK)
- Emergency Genomic Medicine - HUMAN GENOME 2024 (UAE)
- Epigenetics and Gene Regulation - HUMAN GENETICS MEET 2024 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2024 (UAE)
- Evolutionary and Population Genetics - HUMAN GENETICS MEET 2024 (France)
- Functional Genomics and Transcriptomics - HUMAN GENETICS MEET 2024 (France)
- Gene Cloning and Mapping - HUMAN GENETICS MEET 2024 (France)
- Gene Therapy - REGENERATIVE MED MEET 2024 (UK)
- Genes and Immunology - HUMAN GENOME 2024 (UAE)
- Genetic Vaccines - WORLD CELL THERAPY 2024 (UK)
- Genetically Modified Organisms - HUMAN GENOME 2024 (UAE)
- Genome Mapping - HUMAN GENOME 2024 (UAE)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2024 (UAE)
- Genomic Medicine - HUMAN GENOME 2024 (UAE)
- Genomic Technologies in Forensic Science - HUMAN GENOME 2024 (UAE)
- Genomic Vaccination - HUMAN GENOME 2024 (UAE)
- HIV Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Gene Therapy - HUMAN GENOME 2024 (UAE)
- Human Genetics - HUMAN GENETICS MEET 2024 (France)
- Human Genetics and Genomics - HUMAN GENOME 2024 (UAE)
- Immunotherapy - REGENERATIVE MED MEET 2024 (UK)
- Immunotherapy - WORLD CELL THERAPY 2024 (UK)
- Infectious Diseases - HUMAN GENOME 2024 (UAE)
- Models of Regeneration - REGENERATIVE MED MEET 2024 (UK)
- Molecular and Cytogenetics - HUMAN GENETICS MEET 2024 (France)
- Molecular Effects of Genetic Variation - HUMAN GENETICS MEET 2024 (France)
- Molecular Epigenetics - WORLD CELL THERAPY 2024 (UK)
- Molecular Phenotyping and Omics Technologies - HUMAN GENETICS MEET 2024 (France)
- Mutation Detection and Analysis - HUMAN GENETICS MEET 2024 (France)
- Nano-Therapy - WORLD CELL THERAPY 2024 (UK)
- Nanotechnology in Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Nanotechnology in Stem Cell - WORLD CELL THERAPY 2024 (UK)
- Neurodegenerative Disease - Stem Cell 2024 (Ireland)
- New Market Trends, R&D on Stem Cells - Stemgen 2024 (UK)
- Novel Approaches guided in Tissue Engineering - REGENERATIVE MED MEET 2024 (UK)
- Novel Stem Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Orthopedics, Sports Medicine and Regenerative Rehabilitation - REGENERATIVE MED MEET 2024 (UK)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2024 (UAE)
- Pharmacogenomics - HUMAN GENETICS MEET 2024 (France)
- Preimplantation Genetic Diagnosis (PGD) - HUMAN GENOME 2024 (UAE)
- Regeneration and Therapeutics - Stem Cell 2024 (Ireland)
- Regenerative Medicine - Stemgen 2024 (UK)
- Regenerative Medicine in Aging, Dermatology and Plastic Surgery - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine Research - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine research and development - Stemgen 2024 (UK)
- Regenerative Therapy in Osteoarthritis - Stemgen 2024 (UK)
- Research and Development of Stem Cell & Regenerative Drugs - Stem Cell 2024 (Ireland)
- Sickle cell Anaemia Genomics - HUMAN GENETICS MEET 2024 (France)
- Skin Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Stem Cell and Tissue Engineering - Stemgen 2024 (UK)
- Stem Cell Animal Applications - Stem Cell 2024 (Ireland)
- Stem Cell Apoptosis and Signal Transmission - Stem Cell 2024 (Ireland)
- Stem Cell Embryology - Stem Cell 2024 (Ireland)
- Stem cell engineering - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Cardiovascular Disease - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Development - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Discovery - Stem Cell 2024 (Ireland)
- Stem Cell Therapies - WORLD CELL THERAPY 2024 (UK)
- Stem Cell Therapy - Stemgen 2024 (UK)
- Stem cell Transplantation - HUMAN GENETICS MEET 2024 (France)
- Stem Cell Transplantation - Stem Cell 2024 (Ireland)
- Stem Cell Transplantation to Avoid Cancer - Stemgen 2024 (UK)
- Stem Cells - Stem Cell 2024 (Ireland)
- Stem Cells and Disease Modelling - Stemgen 2024 (UK)
- The use of Stem Cells for COVID-19 Therapy - Stemgen 2024 (UK)
- Theories of Aging in Stem Biology - Stem Cell 2024 (Ireland)
- Tissue Engineering - Stem Cell 2024 (Ireland)
- Tissue Science and Engineering - REGENERATIVE MED MEET 2024 (UK)
- Translational Medicine - HUMAN GENETICS MEET 2024 (France)
- Translational Research in Stem Cell Assessments - Stem Cell 2024 (Ireland)
- Viral gene therapy - WORLD CELL THERAPY 2024 (UK)